ISIN | LU0255978859 |
---|---|
Valor Number | 2564984 |
Bloomberg Global ID | BBG000R8WPB9 |
Fund Name | Pictet-Health -R EUR |
Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
Fund Provider | Pictet Asset Management S.A. |
Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Asset Class | Equities |
EFC Category | Equity Health Care |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | To increase the value of your investment while seeking to achieve a positive social impact. The Fund applies a sustainable strategy and invests mainly in equities or similar securities issued by companies that are active in sectors related to health. To safeguard the future of the world’s health services, better prevention and more effective treatments are necessary. These companies help to stem health care costs growth and maximize productivity. The Fund applies a sustainable strategy and invests mainly in equities or similar securities issued by companies that are active in sectors related to health. To safeguard the future of the world’s health services, better prevention and more effective treatments are necessary. These companies help to stem health care costs growth and maximize productivity. |
Peculiarities |
Current Price * | 298.05 EUR | 14.11.2024 |
---|---|---|
Previous Price * | 298.55 EUR | 13.11.2024 |
52 Week High * | 299.79 EUR | 11.11.2024 |
52 Week Low * | 250.00 EUR | 20.11.2023 |
NAV * | 298.05 EUR | 14.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 471,681,621 | |
Unit/Share Assets *** | 98,046,997 | |
Trading Information SIX |
YTD Performance | +11.79% |
29.12.2023 - 14.11.2024
29.12.2023 14.11.2024 |
---|---|---|
YTD Performance (in CHF) | +12.63% |
29.12.2023 - 14.11.2024
29.12.2023 14.11.2024 |
1 month | +2.79% |
14.10.2024 - 14.11.2024
14.10.2024 14.11.2024 |
3 months | +5.27% |
14.08.2024 - 14.11.2024
14.08.2024 14.11.2024 |
6 months | +4.46% |
14.05.2024 - 14.11.2024
14.05.2024 14.11.2024 |
1 year | +19.16% |
14.11.2023 - 14.11.2024
14.11.2023 14.11.2024 |
2 years | +13.20% |
14.11.2022 - 14.11.2024
14.11.2022 14.11.2024 |
3 years | +0.11% |
15.11.2021 - 14.11.2024
15.11.2021 14.11.2024 |
5 years | +24.56% |
14.11.2019 - 14.11.2024
14.11.2019 14.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 0.6564 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 14.11.2024 |
Boston Scientific Corp | 5.93% | |
---|---|---|
Eli Lilly and Co | 5.92% | |
Intuitive Surgical Inc | 5.15% | |
Thermo Fisher Scientific Inc | 5.14% | |
Novo Nordisk AS Class B | 4.92% | |
UnitedHealth Group Inc | 4.46% | |
Lululemon Athletica Inc | 4.42% | |
Lonza Group Ltd | 4.01% | |
Garmin Ltd | 3.74% | |
Danaher Corp | 3.55% | |
Last data update | 31.10.2024 |
TER *** | 2.723% |
---|---|
TER date *** | 31.05.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 2.90% |
Ongoing Charges *** | 2.72% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |
GMOs |